2023 BTF Multidisciplinary Breast Cancer Conference

East Peoria, IL US
April 1, 2023

The BTF Multidisciplinary Breast Cancer Conference is a CME-accredited activity featuring experts in breast cancer. The goal of this activity is to improve the knowledge and competence of learners to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients with breast cancer. The program features in-depth discussion and analysis of the latest scientific findings and practice-changing advances in the field. Expert faculty will aim to place the role of different therapeutic agents in a clinical context and discuss how to utilize these therapeutic options to effectively contribute to patient care. 

Target Audience

  • Medical Oncologists
  • Surgical Oncologists
  • Radiation Oncologists
  • Oncology Fellows
  • Oncology Nurses
  • Nurse Practitioners
  • Physician Assistants
  • Oncology Pharmacists

 

Hotel Information:

Reserve your room by Friday, March 10, 2023, to receive the discounted rate.  Book your room through the following link to get a discounted group rate: 

https://www.hilton.com/en/book/reservation/deeplink/?ctyhocn=PIAESES&groupCode=WCA&arrivaldate=2023-03-31&departuredate=2023-04-02&cid=OM,WW,HILTONLINK,EN,DirectLink&fromId=HILTONLINKDIRECT

Learning Objectives

  1. Review potentially practice-changing abstracts presented at the 2022 San Antonio Breast Cancer Symposium and discuss their application in clinical settings. 
  2. Compare and contrast the safety and efficacy profiles of novel therapeutic strategies that impact breast cancer management.
  3. Integrate emerging evidence into treatment paradigms for the treatment of patients with breast cancer
  4. Individualize management of early-stage or advanced breast cancer patients based on emerging data from clinical trials and evolving expert guidelines.
     
Course summary
Available credit: 
  • 5.25 ABIM MOC II
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.25 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • 5.25 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 5.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 5.25 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 5.25 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 5.25 Contact Hours.
Course opens: 
10/18/2022
Course expires: 
05/24/2023
Event starts: 
04/01/2023 - 8:00am PDT
Event ends: 
04/01/2023 - 3:00pm PDT
Cost:
$200.00
Add to calendar: 

All times are listed in Central Time Zone

Day 1 Friday, March 31

06:00 PM - 07:00 PM: Meet Hematology Oncology Program Director and Faculty- Non-CME Event 

07:00 PM - 08:30 PM: Dinner 

 

Day 2 Saturday, April 1 

07:00 AM – 08:00 AM: Registration/Breakfast/Exhibits

08:00 AM – 08:15 AM: Opening remarks

08:15 AM - 09:15 AM: SESSION 1: Loco-regional Therapy in Breast Cancer

Moderator: Dr. Binay Shah and Dr. Rakesh Mandal

08:15 AM - 08:35 AM: Surgical Management of Breast Cancer- Melanie Barnard, MD

08:35 AM – 08:55 AM: Breast Cancer Radiation Oncology Update- Daniel Ferraro, MD, PhD

08:55 AM – 09:15 AM: Panel Discussion Q & A

09:15 AM – 10:30 AM: SESSION 2: HER2- Breast Cancer

Moderator: Dr. Siddhartha Yadav

09:15 AM – 9:35 AM: Updates in the Management of ER+/HER2- Breast Cancer- Robert Mocharnuk, MD

09:35 AM – 9:55 AM: Systemic Therapy Strategies in Triple-Negative Breast Cancer- Nan Chen, MD

09:55 AM – 10:30 AM: Case-based Panel discussion- Siddhartha Yadav, M.D., F.A.C.P.

10:30 AM – 11:00 AM: Break & Exhibits

11:00 AM - 12:15 PM: SESSION 3: HER2+ Breast Cancer and Precision Oncology

Moderator: Dr. Binay Shah and Dr. Krishna Rao

11:00 AM – 11:20 AM: New Therapeutic Strategies in HER2-Positive Breast Cancer- Nusayba Bagegni, MD

11:20 AM – 11:40 AM: Precision Oncology in Breast Cancer (Tumor-germline Sequencing/CtDNA and other Molecular Guided Therapies) - Jessica Slostad, MD

11:40 AM – 12:00 PM: PARP inhibitors: Current Indication and Toxicities- Siddhartha Yadav, M.D., F.A.C.P.

12:00 PM – 12:15 PM: Case-based Panel discussion- Nyembezi Dhliwayo, MD

12:15 PM — 01:15 PM:  Lunch & Exhibits

01:15 PM - 3:00 PM: SESSION 4: Supportive Care Session

Moderator: Dr. Siddhartha Yadav

01:15 PM — 01:35 PM: Updates on the Use of GCSF/EPO/Luspatercept- Krishna Rao, MD

01:35 PM — 02:05 PM: Updates on Antiemetics- Noor Naffakh, PharmD, MS

02:05 PM — 03:00 PM: Panel Discussion Q & A 

03:00 PM: Adjourn
 

Embassy Suites by Hilton East Peoria Riverfront Hotel & Conference Center
100 Conference Center Dr
East Peoria, IL 61611
United States

A limited number of rooms have been reserved for the attendees of this conference at the Embassy Suites, Peoria, at a discounted rate of $139/night.

Reserve your room by Friday, March 10, 2023, to receive the discounted rate.  Book your room through the following link to get a discounted group rate: 

https://www.hilton.com/en/book/reservation/deeplink/?ctyhocn=PIAESES&groupCode=WCA&arrivaldate=2023-03-31&departuredate=2023-04-02&cid=OM,WW,HILTONLINK,EN,DirectLink&fromId=HILTONLINKDIRECT

IDENTIFICATION AND MITIGATION OF POTENTIAL CONFLICT OF INTERESTS:

All conflict of interest has been identified and mitigated for individuals in control of contents.

PLANNING COMMITTEE DISCLOSURE STATEMENT:

None of the members of the planning committee, nor any member of their immediate families, have a relevant financial interest in or affiliation with any commercial supporter of this educational activity and/or with the manufacturer(s) of commercial products and/or providers of any commercial services discussed in this educational activity.

Course Director(s)

Krishna Rao, MD, PhD

has no relevant financial relationships to disclose at this time.

Siddhartha Yadav, Siddhartha Yadav, MD, FACP

has no relevant financial relationships to disclose at this time.
Speaker/Topic Presenter(s)

Nusayba Bagegni, MD

has a financial relationship (Professional Services) with Total Health Conferencing;.
has a financial relationship (Professional Services) with OncLive/MJH Life Sciences;.

Melanie Barnard

has no relevant financial relationships to disclose at this time.

Nan Chen, MD

has a financial relationship (Professional Services) with AstraZeneca;.
has a financial relationship (Professional Services) with GE Healthcare;.
has a financial relationship (Employment) with GlaxoSmithKline;.
has a financial relationship (Professional Services) with Gilead Oncology;.

Nyembezi Dhliwayo

has no relevant financial relationships to disclose at this time.

Daniel Ferraro

has no relevant financial relationships to disclose at this time.

Robert Mocharnuk, MD, MA, FACP

has a financial relationship (Independent contractor) with AXIS Medical, Inc;.
has a financial relationship (Other) with Merck, Inc;.

Noor Naffakh, PharmD

has no relevant financial relationships to disclose at this time.

Krishna Rao, MD, PhD

has no relevant financial relationships to disclose at this time.

Jessica Slostad, M.D.

has no relevant financial relationships to disclose at this time.

Siddhartha Yadav, Siddhartha Yadav, MD, FACP

has no relevant financial relationships to disclose at this time.
Moderator(s)

Rakesh Mandal, Staff/Consulting Pathologist, OSF St Francis Medical Center

has no relevant financial relationships to disclose at this time.

Krishna Rao, MD, PhD

has no relevant financial relationships to disclose at this time.

Binay Shah, MD, MHA

has no relevant financial relationships to disclose at this time.

Siddhartha Yadav, Siddhartha Yadav, MD, FACP

has no relevant financial relationships to disclose at this time.
Peer reviewer(s)

Binay Shah, MD, MHA

has no relevant financial relationships to disclose at this time.
Planning committee(s)

Rakesh Mandal, Staff/Consulting Pathologist, OSF St Francis Medical Center

has no relevant financial relationships to disclose at this time.

Binay Shah, MD, MHA

has no relevant financial relationships to disclose at this time.

COMMERCIAL SUPPORT ACKNOWLEDGMENT

This activity is supported by an independent medical education grant from the following companies:

  • Gilead Sciences
  • Novartis Pharmaceuticals Corporation

Available Credit

  • 5.25 ABIM MOC II
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.25 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • 5.25 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 5.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 5.25 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 5.25 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 5.25 Contact Hours.

 

Price

Cost:
$200.00
Please login or register to take this course.

REGISTRATION FEES 

Physicians (non-industry) - $200

Non-physician HCP (non-industry) - $75

Industry representatives - $850

NOTICE TO HCPS EMPLOYED BY THE INDUSTRY:

If you are employed by industry, including pharmaceuticals and biotech companies, you must pay the INDUSTRY REGISTRATION FEE to participate in any meeting organized by the Binaytara Foundation. If you misrepresented yourself as a healthcare provider not employed by the industry and failed to pay the Industry registration fee, the following fees apply:

If your company has purchased a display table at the event, you will be billed the full INDUSTRY REGISTRATION FEE plus a fine equivalent to the full industry registration fee for that event = 2 X the industry registration fee.
If your company has NOT purchased a display table at the event AND you attended the meeting without paying a full industry registration fee, you will be billed a full GENERAL DISPLAY FEE for that event. 
Any outstanding display fee, registration fee, and fines must be paid before the industry employee or the company will be able to attend/display at our conferences again.

CANCELLATION POLICY

You may cancel your enrollment at any time. Cancellation fees apply as below:

50% of the paid registration fee will be refunded if registration is cancelled six weeks before the conference.
No refunds will be issued if registration is cancelled after that date.  
No credits will be offered if you do not complete all required steps of this activity which include registration, participation in the live activity, and completion of pre & post tests as well as course evaluations.